These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 3260406

  • 1. [Proteolytic enzymes and their inhibitors in the sputum in chronic processes of the lungs].
    Kaminskaia GO, Zhukova NL, Stepanian IE.
    Sov Med; 1988; (2):38-43. PubMed ID: 3260406
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The kallikrein-kinin system of the blood and protease-protease inhibitor balance in active sarcoidosis].
    Kaminskaia GO, Balta NG, Zhukova NL, Stepanian IE, Lovacheva OV.
    Ter Arkh; 1988; 60(1):70-4. PubMed ID: 3259020
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Alpha-1 antitrypsin in chronic pulmonary diseases].
    Chmielewska D, Gutkowska J.
    Gruzlica; 1975 May; 43(5):455-60. PubMed ID: 1079781
    [No Abstract] [Full Text] [Related]

  • 7. [Blood proteolytic enzyme inhibitors and their clinical study].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1975 May; 21(1):5-13. PubMed ID: 1091093
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment.
    Köhnlein T, Welte T.
    Am J Med; 2008 Jan; 121(1):3-9. PubMed ID: 18187064
    [Abstract] [Full Text] [Related]

  • 11. Alpha 1-antitrypsin deficiency and the impact of nursing interventions and treatment with intravenous therapy. An overview.
    Scharnweber K.
    J Intraven Nurs; 1999 Jan; 22(5):258-64. PubMed ID: 10776189
    [Abstract] [Full Text] [Related]

  • 12. [Biological and clinical features of alpha 1-antitrypsin with special reference to malignant processes. III].
    Millán Núñez-Cortés J.
    Rev Esp Oncol; 1982 Jan; 29(2):325-66. PubMed ID: 6201961
    [No Abstract] [Full Text] [Related]

  • 13. [Alpha 1-antitrypsin in recurrent and chronic respiratory tract diseases].
    Ceglecka-Tomaszewska K, Gutkowska J, Chmielewska-Szewczyk D.
    Pediatr Pol; 1981 Feb; 56(2):133-7. PubMed ID: 6973743
    [No Abstract] [Full Text] [Related]

  • 14. [Elastase activity of the sputum and the functional activity of serum alpha 1-antitrypsin in patients with chronic obstructive pulmonary disease].
    Zhou SW.
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Oct; 11(5):269-70, 318. PubMed ID: 3266105
    [No Abstract] [Full Text] [Related]

  • 15. [Serum levels of alpha-1 antitrypsin in chronic bronchopathies].
    Olivieri D, Brancaccio L, Bocchino M.
    Arch Monaldi; 1973 Oct; 28(5):423-38. PubMed ID: 4215398
    [No Abstract] [Full Text] [Related]

  • 16. Effect of serum alpha1-antitrypsin on the proteolytic activity of purulent sputum.
    Tarján E, Tolnay P.
    Acta Med Acad Sci Hung; 1973 Oct; 30(4):265-9. PubMed ID: 4546043
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prognosis and differential diagnosis of protracted pneumonia using the indicators of inhibition of proteolytic activity].
    Provotorov VM, Semenkova GG.
    Klin Med (Mosk); 1991 Jan; 69(1):91-4. PubMed ID: 2023410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.